Jyong Biotech (JYB) F-1/A Registration statement (foreign) (amended)

Exhibit 23.1

 

Consent of Independent Registered Public Accounting Firm

We hereby consent to the incorporation of our report dated May 8, 2024 in the Registration Statement on Amendment No.1 to Form F-1(No. 333-277725), under the Securities Act of 1933 with respect to the consolidated balance sheets of Jyong Biotech Ltd. and its subsidiaries (collectively the “Group”) as of December 31, 2022 and 2023, and related consolidated statement of operations and comprehensive loss, change in shareholders’ deficit and cash flows, for the years ended December 31, 2022 and 2023, and the related notes included herein.

We also consent to the reference to our firm under the heading “Experts” in the Prospectus.

San Mateo, California	WWC, P.C.
May 8, 2024	Certified Public Accountants
	PCAOB ID: 1171